Search results :

Solifenacin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G04BD08

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Dry mouth 1.5% - 27.6% 4.2% x x x x x x x x
Constipation 5.4% - 13.4% 2.9% x x x x x x x x
Vision blurred 3.8% - 4.8% 1.8% x x x x x x x x
Urinary tract infection 2.8% - 4.8% 2.8% x x x x x x x x
Dyspepsia 1.4% - 3.9% 1% x x x x x x x x
Nausea 1.7% - 3.3% 2% x x x x x x x x
Dizziness 1.8% - 1.9% 1.8% x x x x x x x x
Fatigue 1% - 2.1% 1.1% x x x x x x x x
Influenza 0.9% - 2.2% 1.3% x x x x x x x
Abdominal pain upper 1.2% - 1.9% 1% x x x x x x x
Depression 0.8% - 1.2% 0.8% x x x x x x x
Hypertension 0.5% - 1.4% 0.6% x x x x x x x
Dry eye 0.3% - 1.6% 0.6% x x x x x x x x
Urinary retention 0% - 1.4% 0.6% x x x x x x x x
Pharyngitis 0.3% - 1.1% 1% x x x x x x x
Edema of lower extremities 0.3% - 1.1% 0.7% x x x x x x x
Cough 0.2% - 1.1% 0.2% x x x x x x x
Vomiting 0.2% - 1.1% 0.9% x x x x x x x x
Airway obstruction NOS postmarketing x x x
Anaphylactic shock postmarketing x x x x
Angioedema postmarketing x x x x x x x
Atrial fibrillation postmarketing x x
Confusional state postmarketing x x x x x
Connective tissue disorder postmarketing x
Delirium postmarketing x x x
Dermatitis exfoliative postmarketing x x x x
Erythema multiforme postmarketing x x x x
Rash postmarketing x x x x x x x
Eye disorder postmarketing x x x x x x x x
Gastrooesophageal reflux disease postmarketing x x x
Gastrointestinal disorder postmarketing x x x x x x x x
Glaucoma postmarketing x x x
Hallucination postmarketing x x x x x x x
Headache postmarketing x x x x x
Hyperkalaemia postmarketing x x x
Hypersensitivity postmarketing x x x x x x
Liver disorder postmarketing x x x
Mediastinal disorder postmarketing x x x x x x x x
Palpitations postmarketing x x
Pruritus postmarketing x x x x x x x
Tachycardia postmarketing x x
Torsade de pointes postmarketing x x x x x
Urticaria postmarketing x x x x x x x
Oedema peripheral postmarketing x x x x x
Liver function test abnormal postmarketing x x x x
Muscular weakness postmarketing x
Malnutrition postmarketing x x x
Decreased appetite postmarketing x x x
Ileus postmarketing x x x
Dysphonia postmarketing x x x
Renal impairment postmarketing x x
Somnolence postmarketing x x x x
Abdominal pain x
Mental disorder x x x x x x x x
Infection x x x x x x x x
Cystitis x
Dysgeusia x
Faecalith x x x x x x x x
Cardiac disorder x
Immune system disorder x
Intestinal obstruction x x x x x x x
Nervous system disorder x x x x x x x x
Urinary tract disorder x x x x x x x x
Angiopathy x x x x x x x
Dry skin x
Unspecified disorder of skin and subcutaneous tissue x
Nasal dryness x
Dry throat x
Colon obstruction x x x x x x x x
Strangury x
Drug - food interaction x
Hepatobiliary disease x
Drug interaction x
Infestation NOS x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

SOLIFENACIN SUCCINATE / VESICARE

Side effects:40
Source:Health Canada

SOLIFENACIN SUCCINATE / VESICARE

Side effects:31
Source:FDA

SOLIFENACIN SUCCINATE / VESICARE

Side effects:37
Source:FDA

SOLIFENACIN SUCCINATE / VESICARE

Side effects:38
Source:FDA

SOLIFENACIN

Side effects:45
Source:FDA Structured Product Label

SOLIFENACIN

Side effects:56
Source:FDA Structured Product Label

SOLIFENACIN

Side effects:61
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label